All terms in MESH
| Label | Id | Description |
|---|---|---|
| 1-(5-O-(5-amino-5-deoxyribopentofuranosyl)-5-(4-palmitoylaminohexahydro-2-pyridyl)ribopentofranosyl)uracil | C000604104 | |
| MTCL1 protein, human | C000604105 | |
| legislation & jurisprudence | Q000331 | [Used for laws, statutes, ordinances, or government regulations, as well as for legal controversy and court decisions.] |
| GX-188 vaccine | C000604106 | |
| FLN-1 protein, C elegans | C000604107 | |
| Gro2 protein, zebrafish | C000604108 | |
| sargachromanol I | C000604109 | |
| Histone Methyltransferases | D000076983 | [Enzymes that catalyze the transfer of methyl groups to LYSINE or ARGININE residues of HISTONES, especially histone H3 and histone H4 proteins. They play a critical role in EPIGENETIC PROCESSES.] |
| Protein Methyltransferases | D011496 | [Enzymes that catalyze the methylation of amino acids after their incorporation into a polypeptide chain. S-Adenosyl-L-methionine acts as the methylating agent. EC 2.1.1.] |
| Neonatal Brachial Plexus Palsy | D000076984 | [Perinatal nerve injury involving the BRACHIAL PLEXUS involving a weak or paralyzed upper extremity.] |
| Birth Injuries | D001720 | [Mechanical or anoxic trauma incurred by the infant during labor or delivery.] |
| Brachial Plexus Neuropathies | D020516 | [Diseases of the cervical (and first thoracic) roots, nerve trunks, cords, and peripheral nerve components of the BRACHIAL PLEXUS. Clinical manifestations include regional pain, PARESTHESIA; MUSCLE WEAKNESS, and decreased sensation (HYPESTHESIA) in the upper extremity. These disorders may be associated with trauma (including BIRTH INJURIES); THORACIC OUTLET SYNDROME; NEOPLASMS; NEURITIS; RADIOTHERAPY; and other conditions. (From Adams et al., Principles of Neurology, 6th ed, pp1351-2)] |
| Saporins | D000076985 | [Type 1 ribosome inactivating proteins derived from SAPONARIA OFFICINALIS that function through endohydrolysis of the N-glycosidic bond at single ADENOSINE residues of 28S RIBOSOMAL RNA. They are used as IMMUNOTOXINS.] |
| Ribosome Inactivating Proteins, Type 1 | D054789 | [Ribosome inactivating proteins consisting of only the toxic A subunit, which is a polypeptide of around 30 kDa.] |
| PepE endopeptidase | C105450 | |
| N1,N3-bis(furan-2-ylmethylene)propane-1,3-diamine | C000604100 | |
| PbuX protein, Bacillus subtilis | C105451 | |
| CRISPR-Associated Protein 9 | D000076987 | [An RNA-guided endodeoxyribonuclease that associates with CRISPR SEQUENCES in STREPTOCOCCUS PYOGENES and other bacteria where it participates in an adaptive immune function to cleave foreign DNA complimentary to small GUIDE RNA (sgRNAs). Structurally, Cas9 consists of an ALPHA-HELIX module and a nuclease module connected by a single helix. The nuclease module contains two enzymatic domains: RuvC, which cleaves non-target DNA strand, and an HNH nuclease domain, which cleaves the target strand. Specificity for the DNA target depends on the presence of a protospacer adjacent motif (PAM) sequence, a 2-6 nucleotide DNA sequence immediately following the sequence targeted by Cas9.] |
| CRISPR-Associated Proteins | D064130 | [Protein components of the CRISPR-CAS SYSTEMS for anti-viral defense in ARCHAEA and BACTERIA. These are proteins that carry out a variety of functions during the creation and expansion of the CRISPR ARRAYS, the capture of new CRISPR SPACERS, biogenesis of SMALL INTERFERING RNA (CRISPR or crRNAs), and the targeting and silencing of invading viruses and plasmids. They include DNA HELICASES; RNA-BINDING PROTEINS; ENDONUCLEASES; and RNA and DNA POLYMERASES., A large superfamily of CRISPR-ASSOCIATED PROTEINS that contain at least one RNA recognition motif., Proteins in RIBONUCLEOPROTEIN assemblies of CRISPR-CAS SYSTEMS that function in targeting DNA of invading viruses and plasmids.] |
| Endodeoxyribonucleases | D004706 | [A group of enzymes catalyzing the endonucleolytic cleavage of DNA. They include members of EC 3.1.21.-, EC 3.1.22.-, EC 3.1.23.- (DNA RESTRICTION ENZYMES), EC 3.1.24.- (DNA RESTRICTION ENZYMES), and EC 3.1.25.-.] |